McKesson Corp 每股年股息為 2.7059,收益率為 0.349%。股息每 每季度 支付,最後除權日為 Dec 1, 2025。
股息收益率
年度股息
除息日
0.349%
$2.7059
Dec 1, 2025
付款頻率
派息比例
每季度
8.98%
股利歷史
除息日
現金金額
記錄日期
付款日
Dec 1, 2025
$0.82
Dec 1, 2025
Jan 2, 2026
Sep 2, 2025
$0.82
Sep 2, 2025
Oct 1, 2025
Jun 2, 2025
$0.71
Jun 2, 2025
Jul 1, 2025
Mar 3, 2025
$0.71
Mar 3, 2025
Apr 1, 2025
Dec 2, 2024
$0.71
Dec 2, 2024
Jan 2, 2025
Aug 30, 2024
$0.71
Sep 2, 2024
Oct 1, 2024
股利圖表
MCK 股利
MCK 股息增長(年增率)
360報告
關鍵數據
前收市價
$934.75
開盤價
$945.18
當日範圍
$935.66 - $950
52週區間
$585.22 - $971.93
交易量
551.4K
平均成交量
722.6K
每股盈餘 (TTM)
34.77
股息收益率
0.35%
市值
$116.2B
什麼是 MCK?
McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 43,000 full-time employees. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. The company also offers oncology and specialty solutions.